Literature DB >> 17120209

Molecular mechanisms involved in Ras inactivation: the annexin A6-p120GAP complex.

Thomas Grewal1, Carlos Enrich.   

Abstract

In mammalian cells, a complex network of signaling pathways tightly regulates a variety of cellular processes, such as proliferation and differentiation. New insights from one of the most-important signaling cascades involved in oncogenesis, the Ras-Raf-MAPK pathway, suggest that the subcellular localisation and assembly of signaling modules of this pathway is crucial to control the biological response. This commonly requires membrane targeting events that are mediated by adaptor/scaffold proteins. Of particular interest is the translocation and complex formation of GTPase-activating proteins (GAPs), such as p120GAP, at the plasma membrane to inactivate Ras. Recent studies indicate that one member of the annexin family, annexin A6 acts as a targeting protein for p120GAP. This review discusses how annexin A6 modulates the involvement of negative regulators of the Ras-Raf-MAPK pathway contributing to Ras inactivation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120209     DOI: 10.1002/bies.20503

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  21 in total

Review 1.  Annexins as organizers of cholesterol- and sphingomyelin-enriched membrane microdomains in Niemann-Pick type C disease.

Authors:  Magdalena Domon; Mehmet Nail Nasir; Gladys Matar; Slawomir Pikula; Françoise Besson; Joanna Bandorowicz-Pikula
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

2.  The MMACHC proteome: hallmarks of functional cobalamin deficiency in humans.

Authors:  Luciana Hannibal; Patricia M DiBello; Michelle Yu; Abby Miller; Sihe Wang; Belinda Willard; David S Rosenblatt; Donald W Jacobsen
Journal:  Mol Genet Metab       Date:  2011-03-24       Impact factor: 4.797

3.  Ras, an actor on many stages: posttranslational modifications, localization, and site-specified events.

Authors:  Imanol Arozarena; Fernando Calvo; Piero Crespo
Journal:  Genes Cancer       Date:  2011-03

Review 4.  Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and Interactions.

Authors:  Klaus Scheffzek; Giridhar Shivalingaiah
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

Review 5.  Annexin A6-A multifunctional scaffold in cell motility.

Authors:  Thomas Grewal; Monira Hoque; James R W Conway; Meritxell Reverter; Mohamed Wahba; Syed S Beevi; Paul Timpson; Carlos Enrich; Carles Rentero
Journal:  Cell Adh Migr       Date:  2017-01-06       Impact factor: 3.405

6.  E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases.

Authors:  L Asnaghi; W C Vass; R Quadri; P M Day; X Qian; R Braverman; A G Papageorge; D R Lowy
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

7.  Differential Regulation of RasGAPs in Cancer.

Authors:  Thomas Grewal; Meryem Koese; Francesc Tebar; Carlos Enrich
Journal:  Genes Cancer       Date:  2011-03

8.  Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration.

Authors:  Ana García-Melero; Meritxell Reverter; Monira Hoque; Elsa Meneses-Salas; Meryem Koese; James R W Conway; Camilla H Johnsen; Anna Alvarez-Guaita; Frederic Morales-Paytuvi; Yasmin A Elmaghrabi; Albert Pol; Francesc Tebar; Rachael Z Murray; Paul Timpson; Carlos Enrich; Thomas Grewal; Carles Rentero
Journal:  J Biol Chem       Date:  2015-11-17       Impact factor: 5.157

9.  Plasma membrane-associated annexin A6 reduces Ca2+ entry by stabilizing the cortical actin cytoskeleton.

Authors:  Katia Monastyrskaya; Eduard B Babiychuk; Andrea Hostettler; Peta Wood; Thomas Grewal; Annette Draeger
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

10.  Annexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft.

Authors:  Vikas Saxena; Chao-Kuen Lai; Ti-Chun Chao; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.